Cefpodoxime

Cefpodoxime is a third-generation cephalosporin antibiotic with methoxymethyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(methoxyimino)acetamino substituents at positions 3 and 7, respectively, of the cephem skeleton. Given by mouth as its proxetil ester prodrug, it is used to treat acute otitis media, pharyngitis, and sinusitis. Among its listed roles, it functions as a antibacterial drug. It is a cephalosporin and a carboxylic acid. It is grouped under the following drug class(es): Cephalosporins. Its therapeutic use is listed as anti-infectives, antibacterials and antibiotics. The directory classifies it as a commercial API with a semi-synthetic source/manufacturing origin. Other names for this substance include Cefpodoxime acid and Epoxim. It is listed as a controlled drug substance (Schedule I). Its PubChem CID is 6335986.